Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EnvoyHealth is a specialized healthcare service provider that focuses on patient access and hub services for the pharmaceutical industry. Originally established as a division of Diplomat Pharmacy, the company provides customized solutions to help patients navigate the complexities of specialty medications, including reimbursement support, clinical trial services, and non-commercial pharmacy operations. Following the acquisition of Diplomat by OptumRx in 2020, EnvoyHealth operates as part of the UnitedHealth Group ecosystem. The company leverages data-driven insights and clinical expertise to improve therapy adherence and patient outcomes for complex and rare diseases. By acting as a single point of contact for manufacturers, EnvoyHealth streamlines the journey from prescription to therapy initiation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EnvoyHealth.